Vasoactive intestinal peptide and corticotropin-releasing hormone increase beta-endorphin release and proopiomelanocortin messenger RNA levels in primary cultures of hypothalamic cells: effects of acute and chronic ethanol treatment.

Poplawski, Michael M

Vasoactive intestinal peptide and corticotropin-releasing hormone increase beta-endorphin release and proopiomelanocortin messenger RNA levels in primary cultures of hypothalamic cells: effects of acute and chronic ethanol treatment. [electronic resource] - Alcoholism, clinical and experimental research Apr 2005 - 648-55 p. digital

Publication Type: Journal Article

0145-6008

10.1097/01.alc.0000158834.11252.2e doi


Animals
Cells, Cultured
Central Nervous System Depressants--pharmacology
Corticotropin-Releasing Hormone--administration & dosage
Dose-Response Relationship, Drug
Ethanol--pharmacology
Female
Hypothalamus--cytology
Neurons--drug effects
Pregnancy
Pro-Opiomelanocortin--biosynthesis
RNA--biosynthesis
RNA, Messenger--biosynthesis
Radioimmunoassay
Rats
Rats, Sprague-Dawley
Reverse Transcriptase Polymerase Chain Reaction
Time Factors
Vasoactive Intestinal Peptide--administration & dosage
beta-Endorphin--metabolism